Ahmed Kotb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ahmed Kotb has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Chris Cameron
School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada
2 shared publicationsShuching Hsieh
University of Ottawa Heart Institute, Ottawa, Canada
2 shared publications- Ahmed Salem Eid
Orthopaedic Surgery Department - Faculty of Medicine - Ain Shams University
1 shared publication Ahsan Hadi
Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada
1 shared publicationAnna Savelyeva
Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada
1 shared publication- Becky Skidmore
Independent information specialist, Ottawa, Ontario, Canada
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by Elsevier in Journal of Clinical Orthopaedics and Trauma
- Vol. 11 (1) , 56-61
Cementless jumbo cups for revision of failed Furlong prosthesis. A case series
- 1 January 2020
- Published by Elsevier in Journal of Clinical Orthopaedics and Trauma
- Vol. 11 (1) , 56-61
Open AccessCementless jumbo cups for revision of failed Furlong prosthesis. A case series
- 1 July 2017
- Published by Wolters Kluwer Health in Current Orthopaedic Practice
- Vol. 28 (4) , 398-403
Remodeling after arthroscopic reduction of glenohumeral joint in adduction internal rotation shoulder deformity in obstetric brachial plexus palsy
Background: Lesions of the upper trunk in obstetric brachial plexus palsy (OBPP) commonly leads to long-term shoulder dysfunction. The constant internal rotation lead to early glenohumeral (GH) joint deformity by 6 mo of age and to advanced deformity by 2 yr. Halting or reversing GH deformity and the percentage of the humeral head anterior to the midscapular line is an important surgical goal to restore shoulder function. The purpose of this study was to assess the ability of arthroscopic anterior release (with or without tendon transfers) to correct GH deformity. Methods: Twenty-one patients were included in this study. The average age was 26 mo (17 to 50 mo). Sixteen patients (76.2%) had C5 or 6 lesion, while five (23.8%) had C5, 6 or 7 lesion. Seven patients had grade II GH deformity (33.3%), ten had grade III (47.6%), and four had grade IV (19.1%). Ten children underwent isolated release and 11 underwent concomitant tendon transfers. Functional and radiographic assessments were used to assess outcome after at least 1-year follow-up. The average follow-up period was 19±7 mo (range 12-41 mo). Results: Significant improvement was noted in both the glenohumeral retroversion angle (GRV) angle and percentage of humeral head anterior to the midscapular line at 1-year follow-up The mean preoperative GRV angle was −27.8 degrees and postoperatively −11.8 degrees. The mean percentage of humeral head anterior to the midscapular line was 25% preoperatively and 43% postoperatively. Aggregate Mallet score also demonstrated statistically significant improvement. Conclusions: Arthroscopic release and reduction of GH joint with or without tendon transfer for the sequela of OBPP was associated with GH remodeling. The current study confirmed that the improvement was achieved after nearly 1-year follow-up. The clinical improvements paralleled the radiographic ones. Level of evidence: IV.
- 1 July 2017
- Published by Wolters Kluwer Health in Current Orthopaedic Practice
- Vol. 28 (4) , 398-403
Remodeling after arthroscopic reduction of glenohumeral joint in adduction internal rotation shoulder deformity in obstetric brachial plexus palsy
Background: Lesions of the upper trunk in obstetric brachial plexus palsy (OBPP) commonly leads to long-term shoulder dysfunction. The constant internal rotation lead to early glenohumeral (GH) joint deformity by 6 mo of age and to advanced deformity by 2 yr. Halting or reversing GH deformity and the percentage of the humeral head anterior to the midscapular line is an important surgical goal to restore shoulder function. The purpose of this study was to assess the ability of arthroscopic anterior release (with or without tendon transfers) to correct GH deformity. Methods: Twenty-one patients were included in this study. The average age was 26 mo (17 to 50 mo). Sixteen patients (76.2%) had C5 or 6 lesion, while five (23.8%) had C5, 6 or 7 lesion. Seven patients had grade II GH deformity (33.3%), ten had grade III (47.6%), and four had grade IV (19.1%). Ten children underwent isolated release and 11 underwent concomitant tendon transfers. Functional and radiographic assessments were used to assess outcome after at least 1-year follow-up. The average follow-up period was 19±7 mo (range 12-41 mo). Results: Significant improvement was noted in both the glenohumeral retroversion angle (GRV) angle and percentage of humeral head anterior to the midscapular line at 1-year follow-up The mean preoperative GRV angle was −27.8 degrees and postoperatively −11.8 degrees. The mean percentage of humeral head anterior to the midscapular line was 25% preoperatively and 43% postoperatively. Aggregate Mallet score also demonstrated statistically significant improvement. Conclusions: Arthroscopic release and reduction of GH joint with or without tendon transfer for the sequela of OBPP was associated with GH remodeling. The current study confirmed that the improvement was achieved after nearly 1-year follow-up. The clinical improvements paralleled the radiographic ones. Level of evidence: IV.
- Top Cited Papers
- 14 July 2015
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 55 (S4) , 221-235
Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta‐Analysis
Background: Although triptans are widely used in the acute management of migraine, there is uncertainty around the comparative efficacy of triptans among each other and vs non‐triptan migraine treatments. We conducted systematic reviews and network meta‐analyses to compare the relative efficacy of triptans (alone or in combination with other drugs) for acute treatment of migraines compared with other triptan agents, non‐steroidal anti‐inflammatory drugs ( NSAIDs ), acetylsalicylic acid ( ASA ), acetaminophen, ergots, opioids, or anti‐emetics. Methods: The C ochrane Library, MEDLINE , and EMBASE were searched for randomized controlled trials that compared triptans (alone or in combination with other drugs) with placebo‐controlled or active migraine treatments. Study selection, data extraction, and quality assessment were completed independently by multiple reviewers. Outcome data were combined and analyzed using a B ayesian network meta‐analysis. For each outcome, odds ratios, relative risks, and absolute probability of response were calculated. Results: A total of 133 randomized controlled trials met the inclusion criteria. Standard dose triptans relieved headaches within 2 hours in 42 to 76% of patients, and 2‐hour sustained freedom from pain was achieved for 18 to 50% of patients. Standard dose triptans provided sustained headache relief at 24 hours in 29 to 50% of patients, and sustained freedom from pain in 18 to 33% of patients. Use of rescue medications ranged from 20 to 34%. For 2‐hour headache relief, standard dose triptan achieved better outcomes (42 to 76% response) than ergots (38%); equal or better outcomes than NSAIDs , ASA , and acetaminophen (46 to 52%); and equal or slightly worse outcomes than combination therapy (62 to 80%). Among individual triptans, sumatriptan subcutaneous injection, rizatriptan ODT , zolmitriptan ODT , and eletriptan tablets were associated with the most favorable outcomes. Interpretation/Conclusions: Triptans are effective for migraine relief. Standard dose triptans are associated with better outcomes than ergots, and most triptans are associated with equal or better outcomes compared with NSAIDs , ASA , and acetaminophen. Use of triptans in combination with ASA or acetaminophen, or using alternative modes of administration such as injectables, may be associated with slightly better outcomes than standard dose triptan tablets.
- 14 July 2015
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 55 (S4) , 221-235
Top Cited PapersTriptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta‐Analysis
Background: Although triptans are widely used in the acute management of migraine, there is uncertainty around the comparative efficacy of triptans among each other and vs non‐triptan migraine treatments. We conducted systematic reviews and network meta‐analyses to compare the relative efficacy of triptans (alone or in combination with other drugs) for acute treatment of migraines compared with other triptan agents, non‐steroidal anti‐inflammatory drugs ( NSAIDs ), acetylsalicylic acid ( ASA ), acetaminophen, ergots, opioids, or anti‐emetics. Methods: The C ochrane Library, MEDLINE , and EMBASE were searched for randomized controlled trials that compared triptans (alone or in combination with other drugs) with placebo‐controlled or active migraine treatments. Study selection, data extraction, and quality assessment were completed independently by multiple reviewers. Outcome data were combined and analyzed using a B ayesian network meta‐analysis. For each outcome, odds ratios, relative risks, and absolute probability of response were calculated. Results: A total of 133 randomized controlled trials met the inclusion criteria. Standard dose triptans relieved headaches within 2 hours in 42 to 76% of patients, and 2‐hour sustained freedom from pain was achieved for 18 to 50% of patients. Standard dose triptans provided sustained headache relief at 24 hours in 29 to 50% of patients, and sustained freedom from pain in 18 to 33% of patients. Use of rescue medications ranged from 20 to 34%. For 2‐hour headache relief, standard dose triptan achieved better outcomes (42 to 76% response) than ergots (38%); equal or better outcomes than NSAIDs , ASA , and acetaminophen (46 to 52%); and equal or slightly worse outcomes than combination therapy (62 to 80%). Among individual triptans, sumatriptan subcutaneous injection, rizatriptan ODT , zolmitriptan ODT , and eletriptan tablets were associated with the most favorable outcomes. Interpretation/Conclusions: Triptans are effective for migraine relief. Standard dose triptans are associated with better outcomes than ergots, and most triptans are associated with equal or better outcomes compared with NSAIDs , ASA , and acetaminophen. Use of triptans in combination with ASA or acetaminophen, or using alternative modes of administration such as injectables, may be associated with slightly better outcomes than standard dose triptan tablets.
- Open Access
- 25 February 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (2) , e0118681
Comparative Effectiveness of Different Forms of Telemedicine for Individuals with Heart Failure (HF): A Systematic Review and Network Meta-Analysis
Previous studies on telemedicine have either focused on its role in the management of chronic diseases in general or examined its effectiveness in comparison to standard post-discharge care. Little has been done to determine the comparative impact of different telemedicine options for a specific population such as individuals with heart failure (HF). Systematic reviews (SR) of randomized controlled trials (RCTs) that examined telephone support, telemonitoring, video monitoring or electrocardiographic monitoring for HF patients were identified using a comprehensive search of the following databases: MEDLINE, EMBASE, CINAHL and The Cochrane Library. Studies were included if they reported the primary outcome of mortality or any of the following secondary outcomes: all-cause hospitalization and heart failure hospitalization. Thirty RCTs (N = 10,193 patients) were included. Compared to usual care, structured telephone support was found to reduce the odds of mortality(Odds Ratio 0.80; 95% Credible Intervals [0.66 to 0.96]) and hospitalizations due to heart failure (0.69; [0.56 to 0.85]). Telemonitoring was also found to reduce the odds of mortality(0.53; [0.36 to 0.80]) and reduce hospitalizations related to heart failure (0.64; [0.39 to 0.95]) compared to usual post-discharge care. Interventions that involved ECG monitoring also reduced the odds of hospitalization due to heart failure (0.71; [0.52 to 0.98]). Much of the evidence currently available has focused on the comparing either telephone support or telemonitoring with usual care. This has therefore limited our current understanding of how some of the less common forms of telemedicine compare to one another. Compared to usual care, structured telephone support and telemonitoring significantly reduced the odds of deaths and hospitalization due to heart failure. Despite being the most widely studied forms of telemedicine, little has been done to directly compare these two interventions against one another. Further research into their comparative cost-effectiveness is also warranted.
- 25 February 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (2) , e0118681
Open AccessComparative Effectiveness of Different Forms of Telemedicine for Individuals with Heart Failure (HF): A Systematic Review and Network Meta-Analysis
Previous studies on telemedicine have either focused on its role in the management of chronic diseases in general or examined its effectiveness in comparison to standard post-discharge care. Little has been done to determine the comparative impact of different telemedicine options for a specific population such as individuals with heart failure (HF). Systematic reviews (SR) of randomized controlled trials (RCTs) that examined telephone support, telemonitoring, video monitoring or electrocardiographic monitoring for HF patients were identified using a comprehensive search of the following databases: MEDLINE, EMBASE, CINAHL and The Cochrane Library. Studies were included if they reported the primary outcome of mortality or any of the following secondary outcomes: all-cause hospitalization and heart failure hospitalization. Thirty RCTs (N = 10,193 patients) were included. Compared to usual care, structured telephone support was found to reduce the odds of mortality(Odds Ratio 0.80; 95% Credible Intervals [0.66 to 0.96]) and hospitalizations due to heart failure (0.69; [0.56 to 0.85]). Telemonitoring was also found to reduce the odds of mortality(0.53; [0.36 to 0.80]) and reduce hospitalizations related to heart failure (0.64; [0.39 to 0.95]) compared to usual post-discharge care. Interventions that involved ECG monitoring also reduced the odds of hospitalization due to heart failure (0.71; [0.52 to 0.98]). Much of the evidence currently available has focused on the comparing either telephone support or telemonitoring with usual care. This has therefore limited our current understanding of how some of the less common forms of telemedicine compare to one another. Compared to usual care, structured telephone support and telemonitoring significantly reduced the odds of deaths and hospitalization due to heart failure. Despite being the most widely studied forms of telemedicine, little has been done to directly compare these two interventions against one another. Further research into their comparative cost-effectiveness is also warranted.
- Open Access
- 5 May 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e96581
The Effect of Telephone Support Interventions on Coronary Artery Disease (CAD) Patient Outcomes during Cardiac Rehabilitation: A Systematic Review and Meta-Analysis
Cardiac rehabilitation is offered to individuals after cardiac events to aid recovery and reduce the likelihood of further cardiac illness. However, patient participation remains suboptimal and the provision of high quality care to an expanding population of patients with chronic heart conditions is becoming increasingly difficult. A systematic review and meta-analysis was conducted to determine the effect of telephone support interventions compared with standard post-discharge care on coronary artery disease patient outcomes. The Cochrane Library, MEDLINE, EMBASE, and CINAHL were searched and randomized controlled trials that directly compared telephone interventions with standard post-discharge care in adults following a myocardial infarction or a revascularization procedure were included. Study selection, data extraction and quality assessment were completed independently by two reviewers. Where appropriate, outcome data were combined and analyzed using a random effects model. For each dichotomous outcome, odds ratios (OR) and 95% confidence intervals (CI) were derived for each outcome. For continuous outcomes, weighted mean differences (WMD) and standardized mean differences (SMD) and 95% CI were calculated. 26 studies met the inclusion criteria. No difference was observed in mortality between the telephone group and the group receiving standard care OR 1.12 (0.71, 1.77). The intervention was significantly associated with fewer hospitalizations than the comparison group OR 0.62 (0.40, 0.97). Significantly more participants in the telephone group stopped smoking OR 1.32 (1.07, 1.62); had lower systolic blood pressure WMD −0.22 (−0.40, −0.04); lower depression scores SMD −0.10 (−0.21, −0.00); and lower anxiety scores SMD −0.14 (−0.24, −0.04). However, no significant difference was observed for low-density lipoprotein levels WMD −0.10 (−0.23, 0.03). Compared to standard post-discharge care, regular telephone support interventions may help reduce feelings of anxiety and depression as well as, improve systolic blood pressure control and the likelihood of smoking cessation.
- 5 May 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e96581
Open AccessThe Effect of Telephone Support Interventions on Coronary Artery Disease (CAD) Patient Outcomes during Cardiac Rehabilitation: A Systematic Review and Meta-Analysis
Cardiac rehabilitation is offered to individuals after cardiac events to aid recovery and reduce the likelihood of further cardiac illness. However, patient participation remains suboptimal and the provision of high quality care to an expanding population of patients with chronic heart conditions is becoming increasingly difficult. A systematic review and meta-analysis was conducted to determine the effect of telephone support interventions compared with standard post-discharge care on coronary artery disease patient outcomes. The Cochrane Library, MEDLINE, EMBASE, and CINAHL were searched and randomized controlled trials that directly compared telephone interventions with standard post-discharge care in adults following a myocardial infarction or a revascularization procedure were included. Study selection, data extraction and quality assessment were completed independently by two reviewers. Where appropriate, outcome data were combined and analyzed using a random effects model. For each dichotomous outcome, odds ratios (OR) and 95% confidence intervals (CI) were derived for each outcome. For continuous outcomes, weighted mean differences (WMD) and standardized mean differences (SMD) and 95% CI were calculated. 26 studies met the inclusion criteria. No difference was observed in mortality between the telephone group and the group receiving standard care OR 1.12 (0.71, 1.77). The intervention was significantly associated with fewer hospitalizations than the comparison group OR 0.62 (0.40, 0.97). Significantly more participants in the telephone group stopped smoking OR 1.32 (1.07, 1.62); had lower systolic blood pressure WMD −0.22 (−0.40, −0.04); lower depression scores SMD −0.10 (−0.21, −0.00); and lower anxiety scores SMD −0.14 (−0.24, −0.04). However, no significant difference was observed for low-density lipoprotein levels WMD −0.10 (−0.23, 0.03). Compared to standard post-discharge care, regular telephone support interventions may help reduce feelings of anxiety and depression as well as, improve systolic blood pressure control and the likelihood of smoking cessation.
- Open Access
- 1 August 2012
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. 4, 135-140
Predictive value of CD4 cell count nadir on long-term mortality in HIV-positive patients in Uganda
Peer reviewed article authored by (Bray S, Gedeon J, Hadi A, Kotb A, Rahman T, Sarwar E, Savelyeva A, Sévigny M, Bakanda C, Birungi J, Chan K, Yaya S, Deonandan R, Mills EJ). Read article or submit your manuscript for publishing.
- 1 August 2012
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. 4, 135-140
Open AccessPredictive value of CD4 cell count nadir on long-term mortality in HIV-positive patients in Uganda
Peer reviewed article authored by (Bray S, Gedeon J, Hadi A, Kotb A, Rahman T, Sarwar E, Savelyeva A, Sévigny M, Bakanda C, Birungi J, Chan K, Yaya S, Deonandan R, Mills EJ). Read article or submit your manuscript for publishing.